Demonstrate Compliance, Discuss Strategies for Successful Audits, and Evaluate the Financial Risks and Opportunities of Program Participation
The 5th Annual Covered Entities’ 340B Summit will explore the latest developments in the 340B space with regards to drug pricing transparency, HRSA 340B audits and other federal oversight activities, examine the impact of recent policy changes, consider trends in pharmacy contracting strategies and drug management practices, and strategies to maintain compliance and ensure program integrity.
- Discover how to ensure compliance and program integrity
- Develop audit preparation strategies
- Learn ways to resolve dispute findings between covered entities and drug manufacturers
- Minimize risks and maximize opportunities for financial savings